Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 09 - 12 entities : Amgen inc. save search
Recombinant Proteins Market Size worth USD 633.23 Mn by 2026, Market Analysis Segmented by Application and Geography - Technavio
Published: 2022-09-12 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
|
| O: 1.78%
H: 0.0%
C: 0.0%
TMO | News | $577.39 0.49% -0.38% 1.7M
|
Health Technology
|
| O: -0.34%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -0.72%
H: 0.07%
C: -1.27%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.97%
H: 0.16%
C: -0.98%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: -0.25%
H: 0.05%
C: -4.29%
ABCM | News | $23.99 0.0% 7.4M
|
Health Technology
|
| O: 0.06%
H: 0.83%
C: 0.06%
application market
AMGEN ANNOUNCES WEBCAST OF 2022 BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
Published: 2022-09-12 (Crawled : 22:00) - biospace.com/
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: -3.91%
H: 1.55%
C: -0.16%
america global conference
Entera Bio to Present at H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-12 (Crawled : 21:00) - globenewswire.com
ENTX | $2.07 -6.76% -7.25% 1.2K
|
Health Technology
|
| O: 0.71%
H: 0.72%
C: -1.42%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: -0.25%
H: 0.05%
C: -4.29%
global conference
Entera Bio Presents Dose Proportional Absorption and Correlation to BMD Clinical Response Data from its Phase 2 Study of EB613 in Post-Menopausal Osteoporosis Patients at the ASBMR 2022 Annual Meeting
Published: 2022-09-12 (Crawled : 11:00) - globenewswire.com
ENTX | $2.07 -6.76% -7.25% 1.2K
|
Health Technology
|
| O: 0.72%
H: 6.43%
C: 0.0%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: -3.91%
H: 1.55%
C: -0.16%
eb613 correlation meeting response study osteoporosis
LUMAKRAS® (SOTORASIB) COMBINED WITH VECTIBIX® (PANITUMUMAB) SHOWS CONFIRMED 30% OBJECTIVE RESPONSE RATE IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER
Published: 2022-09-12 (Crawled : 09:00) - prnewswire.com
MS | News 0 d | $93.85 0.1% -0.02% 3.3M
|
Finance
|
| O: 0.6%
H: 1.16%
C: 0.17%
CCXI | News | $51.99 -0.04%
|
Health Technology
|
| O: -0.16%
H: 0.16%
C: 0.06%
BGNE | $144.12 3.69% 3.48% 150
|
Health Technology
|
| O: -1.88%
H: 3.78%
C: 3.73%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: -3.91%
H: 1.55%
C: -0.16%
lumakras response cancer
Celiac Diseases Drugs Market Report by Technavio expects growth to accelerate at 16.95% CAGR
Published: 2022-09-12 (Crawled : 08:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 0
|
Health Technology
|
| O: -4.56%
H: 9.43%
C: 7.62%
SNYNF | News | $94.0 -0.27% -2.18% 0
|
Health Technology
|
| O: -0.78%
H: 0.58%
C: 0.58%
GSK | News | $40.86 -0.92% 0.91% 11K
|
Health Technology
|
| O: 1.44%
H: 1.67%
C: 0.31%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: 0.0%
BLRX | $0.613 -3.74% -6.74% 760K
|
Health Technology
|
| O: -3.3%
H: 1.7%
C: -6.82%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: -3.91%
H: 1.55%
C: -0.16%
report growth market
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 1.2M
|
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.